Atlas Trials

Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma

Clinical trial NCT00051987 · COMPLETED

Trial details

NCT number
NCT00051987
Sponsor
Millennium Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Carcinoma
Start date
2002-12-01
Primary completion
2004-03-01
Enrollment
175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.